Co-Authors
This is a "connection" page, showing publications co-authored by Fausto Baldanti and Antonella Sarasini.
Connection Strength
1.664
-
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study. Int J Infect Dis. 2021 Aug; 109:199-202.
Score: 0.239
-
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area. Clin Microbiol Infect. 2021 Jun; 27(6):914.e1-914.e4.
Score: 0.233
-
Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively. J Clin Microbiol. 2020 08 24; 58(9).
Score: 0.225
-
SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders. Microorganisms. 2020 Jul 15; 8(7).
Score: 0.223
-
Authors' response: COVID-19: how accurate are seroprevalence studies? Euro Surveill. 2020 07; 25(30).
Score: 0.223
-
Molecular detection of gastrointestinal viral infections in hospitalized patients. Diagn Microbiol Infect Dis. 2013 Nov; 77(3):231-5.
Score: 0.139
-
Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol. 2007 Mar; 38(3):244-50.
Score: 0.087
-
Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol. 2006 Jul; 78(7):938-49.
Score: 0.084
-
Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter--spring season. J Clin Virol. 2006 Jan; 35(1):59-68.
Score: 0.079
-
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection. Med (N Y). 2021 Mar 12; 2(3):281-295.e4.
Score: 0.058
-
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 08 07; 12(8):e12697.
Score: 0.056
-
Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. J Med Virol. 2005 Feb; 75(2):336-47.
Score: 0.019